Development of BCR-ABL1-positive ɤδ T-cell leukemia after treatment for thymoma type B1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of BCR-ABL1-positive ɤδ T-cell leukemia after treatment for thymoma type B1

Published:2020-12-07 Issue:5 Volume:62 Page:1259-1262
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Terao Toshiki¹^ORCID,Ashimine Hiroya²,Tsuyama Naoko³,Ikeda Daisuke¹,Kuzume Ayumi¹,Tabata Rikako¹,Tsushima Takafumi¹,Miura Daisuke¹,Narita Kentaro¹^ORCID,Takeuchi Masami¹,Takeuchi Kengo³⁴,Matsue Kosei¹^ORCID

Affiliation:

1. Division of Haematology/Oncology, Department of Internal Medicine, Kameda Medical Centre, Chiba, Japan

2. Division of Oncology, Department of Internal Medicine, Kameda Medical Centre, Chiba, Japan

3. Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

4. Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1856834

Reference12 articles.

1. Epidemiology of Thymoma and Associated Malignancies

2. Thymoma and autoimmunity

3. T-cell lymphocytosis associated with lymphocyte-rich thymoma

4. Delta-T-lymphocytosis in a patient with thymoma

5. Molecular biology of bcr-abl1–positive chronic myeloid leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP